CRSP — CRISPR Therapeutics AGToday's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 7
- all time
- Members · 12m
- 0
- 0 buys · 0 sells · by trade date
- Latest filing
- 10-05
- 2021-10-05
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 1
- 13F holders
- —
- issuer resolved · no holder rows
Congress · disclosure timeline
By trade date · 24 months · 0 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.No dated CRSP rows fall inside the trailing 24 months by trade date.
Members active in CRSP
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).No member disclosed CRSP in the trailing 12 months.
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2021-10-05 | Thomas R. Suozzi D–NY-3 | SELL | Traded 09-20 +15d | $50K–$100K | ||
| 2021-09-23 | Thomas R. Suozzi D–NY-3 | BUY | Traded 06-03 LATE·112d | $50K–$100K | ||
| 2021-02-19 | Marjorie Taylor Greene R–GA-14 | BUY JT (jointly owned) | Traded 01-21 +29d | $1K–$15K | ||
| 2021-01-15 | James M. Inhofe R–OK | SELL partial (partial sale, member-owned) | Traded 01-05 +10d | $1K–$15K | ||
| 2020-12-23 | James M. Inhofe R–OK | SELL partial (partial sale, member-owned) | Traded 12-22 +1d | $50K–$100K | ||
| 2018-06-20 | James M. Inhofe R–OK | SELL partial (partial sale, member-owned) | Traded 06-19 +1d | $15K–$50K | ||
| 2017-11-08 | James M. Inhofe R–OK | BUY | Traded 10-19 +20d | $15K–$50K |
Institutional holders · 13F
Mapped, but not in the published aggregate.
CRSP resolves to CRISPR Therapeutics AG (CIK 1674416), but this build's aggregate holds no entity-keyed top-holder rows for it. CRSP on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to CRISPR Therapeutics AG (CIK 1674416), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Congress ↔ notable managers · CRSP
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers
Not available for CRSP: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗
No moves on either side in the window.